However, in November 2024, the FDA proposed removing oral phenylephrine as an active ingredient in over-the-counter (OTC) nasal decongestant drug products ... During Cold Can children take ...

Natalie Cochran, a former pharmacist who’s on trial in Raleigh County for murdering her husband, will not testify in her trial, backtracking on previous statements made to the court. Natalie informed ...

Promethazine is an antihistamine that ... the defense has described as the drug from Mexico which Michael ordered and took daily. While Michael’s children have testified to Michael’s use ...

Papers were selected based upon one or more of the following key features: epistaxis, epistaxis childhood; bleeding disorders; cauterisation; electrocautery; intranasal topical drug ... In children, ...

Regeneron Pharmaceuticals, Inc. REGN reported fourth-quarter 2024 earnings per share (EPS) of $12.07, which beat the Zacks Consensus Estimate of $11.62. The company recorded an EPS of $11.86 in the ...

Correspondence to Professor Dr Wei Zhao, Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China; wei.zhao{at}rdb.aphp.fr Choosing the right dose ...

Brittany Chan, MD, a pediatrician at Texas Children’s Pediatrics ... so you may accidentally get a double dose if you are also taking acetaminophen for say, a headache or fever. “Cough suppressants ...

Patients were randomized into high and low exposure to dupilumab groups, reproducing the weekly and the eow dosage of the LIBERTY ... In a retrospective chart review by Spergel et al. (168), all the ...

SINGAPORE – The Health Sciences Authority (HSA) said the benefits of pseudoephedrine, a decongestant found in ... allow for easier breathing. But the drug also tightens blood vessels throughout ...

Plus, check out our handy semaglutide weight loss dosage chart for an easy-to-follow overview of what to expect. Semaglutide is the active ingredient in three medications approved by the U.S. Food ...

“Dosing adolescents is the first step in evaluating the safety and PK of nomlabofusp in pediatric patients with FA. We continue to enroll adolescents in our first cohort. This cohort will be ...